Hosted on MSN
Targeting sleeping tumor cells: Oncogene location may determine neuroblastoma's resistance to cancer therapy
Neuroblastoma can be a particularly insidious cancer. In about half of all cases, tumors regress, even without therapy. In the other half, tumors grow very quickly. These tumors often respond well to ...
Biomarker testing for 11 oncogenes at diagnosis enables personalized lung cancer treatment, moving away from a one-size-fits-all approach. Biomarkers serve diagnostic, prognostic, and predictive roles ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results